Aurisco Pharmaceutical is an innovative company dedicated to developing and manufacturing complex Active Pharmaceutical Ingredients (APIs), peptides, and oligonucleotides, serving customers globally. The company utilises advanced technology platforms to develop sustainable processes and generate strong intellectual property for its products. Aurisco operates three cGMP manufacturing sites and provides APIs that cover therapies across respiratory, cardiovascular, oncology, central nervous system, hormones, and antiviral sectors. Additionally, Aurisco offers comprehensive Contract Development and Manufacturing Organisation (CDMO) services, supporting clients through research, development, registration, and commercial manufacturing.

Services include:
– Regulatory Services
– Containment
– APIs (Active Pharmaceutical Ingredients)
– Solid Dosage
– Injectables
– Analytical Services
– Contract Development and Manufacturing (CDMO)
– Complex Synthesis
– Synthetic Biology
– Photochemistry

Aurisco Pharmaceutical is committed to advancing pharmaceutical solutions with a focus on quality and innovation. For more information, please visit aurisco.com.